Target intelligence / Profile preview

Protein arginine N-methyltransferase 5 (PRMT5)

Target
PRMT5
Molecular classification
Type II protein arginine methyltransferase family
01

Overview

Protein arginine N-methyltransferase 5 (PRMT5) is a highly conserved enzyme encoded by the PRMT5 gene. It belongs to the type II protein arginine methyltransferase family and catalyzes the symmetric dimethylation of arginine residues on various protein substrates, including histones and transcription factors. PRMT5 has a characteristic TIM barrel domain and is found in both the cytoplasm and nucleus, with dynamic translocation. Its activity is crucial for numerous biological processes including epigenetic regulation, transcription, cell cycle control, DNA damage response, RNA splicing, and cellular development/differentiation. PRMT5's activity is regulated by protein-protein interactions with adaptor proteins (e.g., CLNS1A, RIOK1, COPR5), complex formation (especially with MEP50), phosphorylation, and C-terminal interactions. Due to its overexpression and critical roles in cancer and other diseases, PRMT5 is considered an important therapeutic target, with strategies including direct enzymatic inhibitors and PPI inhibitors.

02

Mechanism of action

Inhibiting the enzyme's symmetric dimethylation activity or blocking its interaction with adaptor proteins like MEP50.

03

Biological functions

Symmetric dimethylation of arginine residues on histones (H2A, H3, H4) and non-histone proteinsEpigenetic regulation (transcriptional repression and activation via histone methylation)Transcription regulation (methylation of transcription factors like p53, N-MYC, E2F-1, NF-κB/p65, SREBP1, KLF4)Cell cycle regulationDNA damage response (co-activation with p53, influencing DNA repair or apoptosis, regulating splicing of DNA repair genes)RNA splicing and processing (critical role in RNA metabolism, splicing, methylation of Sm proteins)Cellular development and differentiation (essential for embryonic stem cell pluripotency, critical for hematopoiesis)Regulation of ion influx (potentially via interaction with NHERF2)
04

Disease associations

Overexpressed in a wide variety of cancersPlays roles in cellular transformationAssociated with reduced cell death and enhanced proliferation in cancerContributes to oncogenesis through transcriptional changes and post-translational modificationsImplicated in other PRMT5-associated diseases
05

Interacting drugs

Direct enzymatic inhibitors

1 more in the full profile.

Beyond the preview

Go deeper on Protein arginine N-methyltransferase 5 (PRMT5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein arginine N-methyltransferase 5 (PRMT5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call